Why This Downgrade is a "Buy, Buy, Buy!"
August 7, 2023 -
Source: moneymorning.com
Stay updated with breaking news from Greg Madison. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF) CEO Greg Madison speaks to Thomas Warner from Proactive after the commercial-stage specialty pharmaceutical...
Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF) said its Accrufer iron deficiency treatment saw 173% growth in prescriptions in the second quarter, or a 50%...
Shield Therapeutics PLC - Gateshead Quays, England-based commercial stage pharmaceutical company focused on the commercialisation of its oral therapy for iron deficiency - Sees strong prescription...